Johnson & Johnson MedTech Enhances Surgical Robotics with NVIDIA AI Integration

Published: 31 Oct 2025

Author: Precedence Research

Share :

Johnson & Johnson MedTech made a major step forward in the field of surgical robotics and the intelligent operating room. Introducing its surgical robotics platforms with physical artificial intelligence (AI) technology to develop high-fidelity simulated environments through NVIDIA Isaac in Healthcare.

The improved system serves as the foundation for the MONARCH Urology system within the company. This enables clinical staff to practice robotic surgery in virtual operating rooms and then transfer their skills to the real operating room. The simulation platform is used to create artificial anatomy and diverse clinical scenarios, including kidney stone surgeries, to facilitate surgical planning, education, and outcomes enhancement, according to J&J.

The partnership incorporates the NVIDIA Omniverse libraries for developing a digital twin and the NVIDIA Cosmos World Foundation models to generate synthetic data that reflects physics-based behaviors. This enables the research and development teams at J&J MedTech to test the entire robotic system, including the tower, cart, fluid-management system, and instruments.

Combined with the 510(k) clearance of the MONARCH Quest system earlier this year, the launch of AI-based simulation marks a strategic shift toward intelligent, system-wide surgical systems rather than single-use machines. Furthermore, as hospitals increasingly demand integrated solutions, robotics, digital twins, and AI could define the future of surgical treatment.

Executives’ Statements:

Neda Cvijetic, Senior VP & Global Head of Robotics & Digital R&D, MedTech, Johnson & Johnson:

“Simulation is the next frontier in surgical robotics. With AI-driven simulation, we can create high-fidelity digital twins that adhere to the laws of physics, enabling simulations to accurately anticipate the real world and ultimately unlocking physical AI capabilities. As we launch new robotics technologies and continue accelerating our innovation pipeline, these simulations have the potential to enhance our differentiated technology development in support of our mission to deliver better patient outcomes.”

Aleksandra Popovic, President, MONARCH, MedTech, Johnson & Johnson:

“This is an exciting development in our use of AI to shape our robotics portfolio and position the MONARCH Platform for Urology for success. Our teams are convening the right technologies to capture value from data and shape new experiences with our systems before, during, and after surgery.”